As CMOs become Integrated into Pharmaceutical Businesses' Value Chains, This Business Model is Projected to be a Resounding Success
As an alternative to pharmaceutical corporations' in-house research and production divisions, contract manufacturing organisations (CMOs) have emerged in the last several decades. As contract manufacturing organisations (CMOs) become more and more integrated into pharmaceutical businesses' value chains, this business model is proving to be a resounding success. The industry as a whole is growing, but many CMOs are having to deal with difficulties they have never faced before. Because of intense competition, rising costs, ongoing technical advancements, and an increase in merger and acquisition activity, businesses are forced to consider what actions they might take to protect or enhance their position in this competitive market.
CMO of Sterile Injectable Drugs Market Growth Drivers
• Outsourced biologic drug product production capabilities
• High growth in developing markets
• Lucrative demand for biologics
• More sterile injectable drugs are losing their patents, including biologics, and the generic parenteral and biosimilar markets are growing
• Increased demand for patient-friendly parenteral administration methods and prefilled syringes
• The ageing population and the ailments that come with it (cancer, diabetes, autoimmune, metabolic, nervous system disorders, etc.)
• High-potency (HPAPI and cytotoxic) medicinal product production
• Adding second-source drug product manufacturers to the supply chain reduces supply chain risk
What Factors Are Challenging Market Growth
• Capabilities in analytical development and/or testing
• Identifying CMOs with ADC filling capability
• Available sterile filling capacity for modest amounts
• Visual inspection
• Assay transfer
What are the Market Opportunities?
• Emerging business segments and economies
• India is a favorable sourcing destination for injectables
• Increasing outsourcing activities by major pharmaceutical companies towards emerging markets for cost savings
Discover how to stay ahead
Our 520+ page report provides 680+ tables and charts/graphs. Read on to discover the most lucrative areas in the industry and the future market prospects. Our new study lets you assess forecasted sales at overall world market and regional level. See financial results, trends, opportunities, and revenue predictions. Much opportunity remains in this growing Contract Manufacturing Outsourcing (CMO) of Sterile Injectable Drugs Market. See how to exploit the opportunities.
This report includes data analysis and invaluable insight into how COVID-19 will affect your industry. Access this report today.
Forecasts to 2031 and other analyses reveal the commercial prospects
• In addition to revenue forecasting to 2031, our new study provides you with recent results, growth rates, and market shares.
• You find original analyses, with business outlooks and developments.
• Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints, and challenges), PEST Analysis, Porter’s Five Forces, SWOT Analysis, product profiles and commercial developments.
Discover sales predictions for the world market and sub-markets
Molecule Type
• Small Molecule
• Large Molecule
Type
• Monoclonal Antibodies (mAbs)
• Cytokines
• Insulin
• Peptide Hormones
• Vaccines
• Immunoglobulins
• Blood Factors
• Peptide Antibiotics
• Others
Application
• Cancer
• Diabetes
• Cardiovascular Diseases
• CNS
• Infectious
• Others
Container Type
• Bottles
• Ampoules
• Vials
• Prefilled Syringes
• Bags
Route of Administration
• Subcutaneous (SC)
• Intravenous (IV)
• Intramuscular (IM)
• Others
Service
• Bioanalytical Testing
• Method Development & Validation
• Stability Testing
• Others
In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for 5 regional and 17 leading national markets:
By Region
• North America
• U.S.
• Canada
• Europe
• Germany
• France
• UK
• Italy
• Spain
• Russia
• Rest of Europe
• Asia Pacific
• China
• Japan
• India
• Australia
• South-East Asia
• Rest of Asia Pacific
• Latin America
• Brazil
• Mexico
• Rest of Latin America
• Middle East & Africa
• GCC
• South Africa
• Rest of Middle East & Africa
Leading companies and the potential for market growth
Overall world revenue for contract manufacturing outsourcing (CMO) of sterile injectable drugs Market will surpass $xx billion in 2021, our work calculates. We predict strong revenue growth through to 2031. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.
Prospects for established firms and those seeking to enter the market– including company profiles for 17 of the major companies involved in the contract manufacturing outsourcing (CMO) of sterile injectable drugs market. Some of the companies profiled in this report include Aenova Group, Almac Group, Baxter Biopharma Solutions, Boehringer Ingelheim, Catalent, Inc., CordenPharma, Evonik Industries AG, Famar Health Care Services, Fresenius Kabi Ag, Grifols SA, Hikma Pharmaceuticals PLC, Jubilant Pharmova Limited, Lonza, Patheon, Inc. (Thermo Fischer), Pfizer CentreOne, Recipharm AB, and Siegfried Holding AG among other prominent players.
How the Contract Manufacturing Outsourcing (CMO) of Sterile Injectable Drugs Market report helps you
In summary, our 500+ page report provides you with the following knowledge:
• Revenue forecasts to 2031 for Contract Manufacturing Outsourcing (CMO) of Sterile Injectable Drugs Market, with forecasts for 2 molecule types, 8 types, 6 applications, 5 container types, 4 route of administration, and 4 services, each forecasted at a global and regional level– discover the industry’s prospects, finding the most lucrative places for investments and revenues
• Revenue forecasts to 2031 for 5 regional and 17 key national markets– See forecasts for the Contract Manufacturing Outsourcing (CMO) of Sterile Injectable Drugs market in North America, Europe, Asia Pacific, and Rest of the World. These regional markets have been further bifurcated by countries including US, Canada, Brazil, Mexico, Germany, France, UK, Italy, Spain, Russia, China, India, Japan, Australia, South Korea, and South-East Asia among other prominent economies.
• Prospects for established firms and those seeking to enter the market– including company profiles for 17 of the companies involved in the Contract Manufacturing Outsourcing (CMO) of Sterile Injectable Drugs Market. Some of the company’s profiled in this report include Aenova Group, Almac Group, Baxter Biopharma Solutions, Boehringer Ingelheim, Catalent, Inc., CordenPharma, Evonik Industries AG, Famar Health Care Services, Fresenius Kabi Ag, Grifols SA, Hikma Pharmaceuticals PLC, Jubilant Pharmova Limited, Lonza, Patheon, Inc. (Thermo Fischer), Pfizer CentreOne, Recipharm AB, and Siegfried Holding AG among other prominent players.
Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with this invaluable business intelligence.
Information found nowhere else
With our newly report title, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions. Our study is for everybody needing commercial analyses for the Contract Manufacturing Outsourcing (CMO) of Sterile Injectable Drugs Market and leading companies. You will find data, trends, and predictions.
'
1. Report Overview
1.1 Introduction to CMO of Sterile Injectable Drugs Market
1.2 CMO of Sterile Injectable Drugs Market Definition
1.3 Why You Should Read This Report
1.4 What This Report Delivers
1.5 Key Questions Answered By This Analytical Report Include:
1.6 Who is This Report For?
1.7 Methodology
1.7.1 COVID-19 Impact: Recovery Scenarios
1.7.2 Market Evaluation & Forecasting Methodology
1.8 Frequently Asked Questions (FAQs)
1.9 Associated Reports
1.10 About
2 Executive Summary
3 Market Dynamics
3.1 Drivers
3.1.1 More sterile injectable drugs are losing their patents, including biologics, and the generic parenteral and biosimilar markets are growing
3.1.2 Lucrative demand for biologics
3.1.3 The ageing population and the ailments that come with it (cancer, diabetes, autoimmune, metabolic, nervous system disorders, etc.)
3.2 Restraints
3.2.1 Capabilities in analytical development and testing
3.2.2 Available sterile filling capacity for modest amounts anticipated to restrain market growth
3.3 Opportunities
3.3.1 Emerging business segments and economies
3.3.2 Increasing outsourcing activities by major pharmaceutical companies towards emerging markets for cost savings
3.4 SWOT Analysis
3.4.1 Strengths
3.4.2 Weaknesses
3.4.3 Opportunities
3.4.4 Threats
3.5 Porter’s Five Forces Analysis
3.5.1 Buyer Power
3.5.2 Supplier Power
3.5.3 Competitive Rivalry
3.5.4 Threat of Substitute
3.5.5 Threat of New Entrants
3.6 PEST Analysis
3.6.1 Political Factors Impacting CMO of Sterile Injectable Drugs Market
3.6.2 Economic Factors Impacting CMO of Sterile Injectable Drugs Market
3.6.3 Social Factors Impacting CMO of Sterile Injectable Drugs Market
3.6.4 Technological Factors Impacting CMO of Sterile Injectable Drugs Market
4 CMO of Sterile Injectable Drugs Market by Molecule Type
4.1 Small Molecule Segment Market Forecast, 2021-2031
4.1.1 Small Molecules Segment Market Overview
4.1.2 COVID-19 Impact Recovery Scenarios (V, U, W, L)
4.2 Large Molecule Segment Market Forecast, 2021-2031
4.2.1 Large Molecules Segment Market Overview
4.2.2 COVID-19 Impact Recovery Scenarios (V, U, W, L)
5 CMO of Sterile Injectable Drugs Market by Type
5.1 Monoclonal Antibodies (mAbs) Segment Market Forecast, 2021-2031
5.1.1 Monoclonal Antibodies (mAbs) Segment Market Overview
5.1.2 COVID-19 Impact Recovery Scenarios (V, U, W, L)
5.2 Cytokines Segment Market Forecast, 2021-2031
5.2.1 Cytokines Segment Market Overview
5.2.2 COVID-19 Impact Recovery Scenarios (V, U, W, L)
5.3 Insulin Segment Market Forecast, 2021-2031
5.3.1 Insulin Segment Market Overview
5.3.2 COVID-19 Impact Recovery Scenarios (V, U, W, L)
5.4 Peptide Hormones Segment Market Forecast, 2021-2031
5.4.1 Peptide Hormones Segment Market Overview
5.4.2 COVID-19 Impact Recovery Scenarios (V, U, W, L)
5.5 Vaccines Segment Market Forecast, 2021-2031
5.5.1 Vaccines Segment Market Overview
5.5.2 COVID-19 Impact Recovery Scenarios (V, U, W, L)
5.6 Immunoglobulins Segment Market Forecast, 2021-2031
5.6.1 Immunoglobulins Segment Market Overview
5.6.2 COVID-19 Impact Recovery Scenarios (V, U, W, L)
5.7 Blood Factors Segment Market Forecast, 2021-2031
5.7.1 Blood Factors Segment Market Overview
5.7.2 COVID-19 Impact Recovery Scenarios (V, U, W, L)
5.8 Peptide Antibiotics Segment Market Forecast, 2021-2031
5.8.1 Peptide Antibiotics Segment Market Overview
5.8.2 COVID-19 Impact Recovery Scenarios (V, U, W, L)
5.9 Others Segment Market Forecast, 2021-2031
5.9.1 COVID-19 Impact Recovery Scenarios (V, U, W, L)
6 CMO of Sterile Injectable Drugs Market by Application
6.1 Cancer Segment Market Forecast, 2021-2031
6.1.1 Cancer Segment Market Overview
6.1.2 COVID-19 Impact Recovery Scenarios (V, U, W, L)
6.2 Diabetes Segment Market Forecast, 2021-2031
6.2.1 Diabetes Segment Market Overview
6.2.2 COVID-19 Impact Recovery Scenarios (V, U, W, L)
6.3 Cardiovascular Diseases Segment Market Forecast, 2021-2031
6.3.1 Cardiovascular Diseases Segment Market Overview
6.3.2 COVID-19 Impact Recovery Scenarios (V, U, W, L)
6.4 CNS Segment Market Forecast, 2021-2031
6.4.1 CNS Segment Market Overview
6.4.2 COVID-19 Impact Recovery Scenarios (V, U, W, L)
6.5 Infectious Segment Market Forecast, 2021-2031
6.5.1 Infectious Segment Market Overview
6.5.2 COVID-19 Impact Recovery Scenarios (V, U, W, L)
6.6 Others Segment Market Forecast, 2021-2031
6.6.1 Others Segment Market Overview
6.6.2 COVID-19 Impact Recovery Scenarios (V, U, W, L)
7 CMO of Sterile Injectable Drugs Market by Container Type
7.1 Bottles Segment Market Forecast, 2021-2031
7.1.1 Bottles Segment Market Overview
7.1.2 COVID-19 Impact Recovery Scenarios (V, U, W, L)
7.2 Ampoules Segment Market Forecast, 2021-2031
7.2.1 Ampoules Segment Market Overview
7.2.2 COVID-19 Impact Recovery Scenarios (V, U, W, L)
7.3 Vials Segment Market Forecast, 2021-2031
7.3.1 Vials Segment Market Overview
7.3.2 COVID-19 Impact Recovery Scenarios (V, U, W, L)
7.4 Prefilled Syringes Segment Market Forecast, 2021-2031
7.4.1 Prefilled Syringes Segment Market Overview
7.4.2 COVID-19 Impact Recovery Scenarios (V, U, W, L)
7.5 Bags Segment Market Forecast, 2021-2031
7.5.1 Bags Segment Revenue, 2021-2031
7.5.2 COVID-19 Impact Recovery Scenarios (V, U, W, L)
8 CMO of Sterile Injectable Drugs Market by Route of Administration
8.1 Subcutaneous (SC) Segment Market Forecast, 2021-2031
8.1.1 Subcutaneous (SC) Segment Revenue, 2021-2031
8.1.2 COVID-19 Impact Recovery Scenarios (V, U, W, L)
8.2 Intravenous (IV) Segment Market Forecast, 2021-2031
8.2.1 Intravenous (IV) Segment Revenue, 2021-2031
8.2.2 COVID-19 Impact Recovery Scenarios (V, U, W, L)
8.3 Intramuscular (IM) Segment Market Forecast, 2021-2031
8.3.1 Intramuscular Segment Revenue, 2021-2031
8.3.2 COVID-19 Impact Recovery Scenarios (V, U, W, L)
8.4 Others Segment Market Forecast, 2021-2031
8.4.1 Others Segment Revenue, 2021-2031
8.4.2 COVID-19 Impact Recovery Scenarios (V, U, W, L)
9 CMO of Sterile Injectable Drugs Market by Service
9.1 Bioanalytical Testing Segment Market Forecast, 2021-2031
9.1.1 Bioanalytical Testing Segment Revenue, 2021-2031
9.1.2 COVID-19 Impact Recovery Scenarios (V, U, W, L)
9.2 Method Development & Validation Segment Market Forecast, 2021-2031
9.2.1 Method Development & Validation Segment Revenue, 2021-2031
9.2.2 COVID-19 Impact Recovery Scenarios (V, U, W, L)
9.3 Stability Testing Segment Market Forecast, 2021-2031
9.3.1 Stability Testing Segment Revenue, 2021-2031
9.3.2 COVID-19 Impact Recovery Scenarios (V, U, W, L)
9.4 Others Segment Market Forecast, 2021-2031
9.4.1 Others Segment Revenue, 2021-2031
9.4.2 COVID-19 Impact Recovery Scenarios (V, U, W, L)
10 Regional and Leading National CMO of Sterile Injectable Drugs Market Forecasts 2021-2031
10.1 Global CMO of Sterile Injectable Drugs Market by Region Forecast 2021-2031
10.2 COVID-19 Impact Recovery Scenarios (V, U, W, L)
11 North America CMO of Sterile Injectable Drugs Market
11.1 North American CMO of Sterile Injectables Market Outlook
11.2 North America CMO of Sterile Injectable Drugs Market by Country, Forecast 2021-2031
11.3 North America CMO of Sterile Injectable Drugs Market Forecast by Molecule Type
11.4 North America CMO of Sterile Injectable Drugs Market Forecast by Type
11.5 North America CMO of Sterile Injectable Drugs Market Forecast by Application
11.6 North America CMO of Sterile Injectable Drugs Market Forecast by Container Type
11.7 North America CMO of Sterile Injectable Drugs Market Forecast by Route of Administration
11.8 North America CMO of Sterile Injectable Drugs Market Forecast by Service
11.9 U.S. CMO of Sterile Injectable Drugs Market Forecast, 2021-2031
11.9.1 U.S. CMO of Sterile Injectables Market Outlook
11.9.2 U.S. CMO of Sterile Injectables Market Revenue, 2021-2031
11.9.3 COVID-19 Impact Recovery Scenarios (V, U, W, L): U.S. CMO of Sterile Injectable Drugs Market Forecast, 2021-2031
11.10 Canada CMO of Sterile Injectable Drugs Market Forecast, 2021-2031
11.10.1 Canada CMO of Sterile Injectables Market Outlook
11.10.2 Canada CMO of Sterile Injectables Market Revenue, 2021-2031
11.10.3 COVID-19 Impact Recovery Scenarios (V, U, W, L): Canada CMO of Sterile Injectable Drugs Market Forecast, 2021-2031
12 Europe CMO of Sterile Injectable Drugs Market
12.1 European CMO of Sterile Injectables Market Outlook
12.2 Europe CMO of Sterile Injectable Drugs Market by Country, Forecast 2021-2031
12.3 Europe CMO of Sterile Injectable Drugs Market Forecast by Molecule Type
12.4 Europe CMO of Sterile Injectable Drugs Market Forecast by Type
12.5 Europe CMO of Sterile Injectable Drugs Market Forecast by Application
12.6 Europe CMO of Sterile Injectable Drugs Market Forecast by Container Type
12.7 Europe CMO of Sterile Injectable Drugs Market Forecast by Route of Administration
12.8 Europe CMO of Sterile Injectable Drugs Market Forecast by Service
12.9 Germany CMO of Sterile Injectable Drugs Market Forecast, 2021-2031
12.9.1 Germany CMO of Sterile Injectables Market Outlook
12.9.2 Germany CMO of Sterile Injectables Market Revenue, 2021-2031
12.9.3 COVID-19 Impact Recovery Scenarios (V, U, W, L): Germany CMO of Sterile Injectable Drugs Market Forecast, 2021-2031
12.10 UK CMO of Sterile Injectable Drugs Market Forecast, 2021-2031
12.10.1 UK CMO of Sterile Injectables Market Outlook
12.10.2 UK CMO of Sterile Injectables Market Revenue, 2021-2031
12.10.3 COVID-19 Impact Recovery Scenarios (V, U, W, L): UK CMO of Sterile Injectable Drugs Market Forecast, 2021-2031
12.11 France CMO of Sterile Injectable Drugs Market Forecast, 2021-2031
12.11.1 France CMO of Sterile Injectables Market Outlook
12.11.2 France CMO of Sterile Injectables Market Revenue, 2021-2031
12.11.3 COVID-19 Impact Recovery Scenarios (V, U, W, L): France CMO of Sterile Injectable Drugs Market Forecast, 2021-2031
12.12 Italy CMO of Sterile Injectable Drugs Market Forecast, 2021-2031
12.12.1 Italy CMO of Sterile Injectables Market Outlook
12.12.2 Italy CMO of Sterile Injectables Market Revenue, 2021-2031
12.12.3 COVID-19 Impact Recovery Scenarios (V, U, W, L): Italy CMO of Sterile Injectable Drugs Market Forecast, 2021-2031
12.13 Spain CMO of Sterile Injectable Drugs Market Forecast, 2021-2031
12.13.1 Spain CMO of Sterile Injectables Market Outlook
12.13.2 Spain CMO of Sterile Injectables Market Revenue, 2021-2031
12.13.3 COVID-19 Impact Recovery Scenarios (V, U, W, L): Spain CMO of Sterile Injectable Drugs Market Forecast, 2021-2031
12.14 Russia CMO of Sterile Injectable Drugs Market Forecast, 2021-2031
12.14.1 Russia CMO of Sterile Injectables Market Outlook
12.14.2 Russia CMO of Sterile Injectables Market Revenue, 2021-2031
12.14.3 COVID-19 Impact Recovery Scenarios (V, U, W, L): Russia CMO of Sterile Injectable Drugs Market Forecast, 2021-2031
12.15 Rest of Europe CMO of Sterile Injectable Drugs Market Forecast, 2021-2031
12.15.1 Rest of Europe CMO of Sterile Injectables Market Outlook
12.15.2 Rest of Europe CMO of Sterile Injectables Market Revenue, 2021-2031
12.15.3 COVID-19 Impact Recovery Scenarios (V, U, W, L): Rest of Europe CMO of Sterile Injectable Drugs Market Forecast, 2021-2031
13 Asia Pacific CMO of Sterile Injectable Drugs Market
13.1 Asia Pacific CMO of Sterile Injectables Market Outlook
13.2 Asia Pacific CMO of Sterile Injectable Drugs Market by Country, Forecast 2021-2031
13.3 Asia Pacific CMO of Sterile Injectable Drugs Market Forecast by Molecule Type
13.4 Asia Pacific CMO of Sterile Injectable Drugs Market Forecast by Type
13.5 Asia Pacific CMO of Sterile Injectable Drugs Market Forecast by Application
13.6 Asia Pacific CMO of Sterile Injectable Drugs Market Forecast by Container Type
13.7 Asia Pacific CMO of Sterile Injectable Drugs Market Forecast by Route of Administration
13.8 Asia Pacific CMO of Sterile Injectable Drugs Market Forecast by Service
13.9 Japan CMO of Sterile Injectable Drugs Market Forecast, 2021-2031
13.9.1 Japan CMO of Sterile Injectables Market Outlook
13.9.2 Japan CMO of Sterile Injectables Market Revenue, 2021-2031
13.9.3 COVID-19 Impact Recovery Scenarios (V, U, W, L): Japan CMO of Sterile Injectable Drugs Market Forecast, 2021-2031
13.10 China CMO of Sterile Injectable Drugs Market Forecast, 2021-2031
13.10.1 China CMO of Sterile Injectables Market Outlook
13.10.2 China CMO of Sterile Injectables Market Revenue, 2021-2031
13.10.3 COVID-19 Impact Recovery Scenarios (V, U, W, L): China CMO of Sterile Injectable Drugs Market Forecast, 2021-2031
13.11 India CMO of Sterile Injectable Drugs Market Forecast, 2021-2031
13.11.1 India CMO of Sterile Injectables Market Outlook
13.11.2 India CMO of Sterile Injectables Market Revenue, 2021-2031
13.11.3 COVID-19 Impact Recovery Scenarios (V, U, W, L): India CMO of Sterile Injectable Drugs Market Forecast, 2021-2031
13.12 Australia CMO of Sterile Injectable Drugs Market Forecast, 2021-2031
13.12.1 Australia CMO of Sterile Injectables Market Outlook
13.12.2 Australia CMO of Sterile Injectables Market Revenue, 2021-2031
13.12.3 COVID-19 Impact Recovery Scenarios (V, U, W, L): Australia CMO of Sterile Injectable Drugs Market Forecast, 2021-2031
13.13 South-East Asia CMO of Sterile Injectable Drugs Market Forecast, 2021-2031
13.13.1 South-East Asia CMO of Sterile Injectables Market Revenue, 2021-2031
13.13.2 COVID-19 Impact Recovery Scenarios (V, U, W, L): South-East Asia CMO of Sterile Injectable Drugs Market Forecast, 2021-2031
13.14 Rest of Asia Pacific CMO of Sterile Injectable Drugs Market Forecast, 2021-2031
13.14.1 Rest of Asia Pacific CMO of Sterile Injectables Market Outlook
13.14.2 Rest of Asia Pacific CMO of Sterile Injectables Market Revenue, 2021-2031
13.14.3 COVID-19 Impact Recovery Scenarios (V, U, W, L): Rest of Asia Pacific CMO of Sterile Injectable Drugs Market Forecast, 2021-2031
14 Latin America CMO of Sterile Injectable Drugs Market
14.1 Latin American CMO of Sterile Injectables Market Outlook
14.2 Latin America CMO of Sterile Injectable Drugs Market by Country, Forecast 2021-2031
14.3 Latin America CMO of Sterile Injectable Drugs Market Forecast by Molecule Type
14.4 Latin America CMO of Sterile Injectable Drugs Market Forecast by Type
14.5 Latin America CMO of Sterile Injectable Drugs Market Forecast by Application
14.6 Latin America CMO of Sterile Injectable Drugs Market Forecast by Container Type
14.7 Latin America CMO of Sterile Injectable Drugs Market Forecast by Route of Administration
14.8 Latin America CMO of Sterile Injectable Drugs Market Forecast by Service
14.9 Brazil CMO of Sterile Injectable Drugs Market Forecast, 2021-2031
14.9.1 Brazil CMO of Sterile Injectables Market Outlook
14.9.2 Brazil CMO of Sterile Injectables Market Revenue, 2021-2031
14.9.3 COVID-19 Impact Recovery Scenarios (V, U, W, L): Brazil CMO of Sterile Injectable Drugs Market Forecast, 2021-2031
14.10 Mexico CMO of Sterile Injectable Drugs Market Forecast, 2021-2031
14.10.1 Mexico CMO of Sterile Injectables Market Outlook
14.10.2 Mexico CMO of Sterile Injectables Market Revenue, 2021-2031
14.10.3 COVID-19 Impact Recovery Scenarios (V, U, W, L): Mexico CMO of Sterile Injectable Drugs Market Forecast, 2021-2031
14.11 Rest of Latin America CMO of Sterile Injectable Drugs Market Forecast, 2021-2031
14.11.1 Rest of Latin America CMO of Sterile Injectables Market Outlook
14.11.2 Rest of Latin America CMO of Sterile Injectables Market Revenue, 2021-2031
14.11.3 COVID-19 Impact Recovery Scenarios (V, U, W, L): Rest of Latin America CMO of Sterile Injectable Drugs Market Forecast, 2021-2031
15 Middle East and Africa CMO of Sterile Injectable Drugs Market
15.1 Middle East and Africa CMO of Sterile Injectables Market Outlook
15.2 Middle East and Africa CMO of Sterile Injectable Drugs Market by Country, Forecast 2021-2031
15.3 Middle East and Africa CMO of Sterile Injectable Drugs Market Forecast by Molecule Type
15.4 Middle East and Africa CMO of Sterile Injectable Drugs Market Forecast by Type
15.5 Middle East and Africa CMO of Sterile Injectable Drugs Market Forecast by Application
15.6 Middle East and Africa CMO of Sterile Injectable Drugs Market Forecast by Container Type
15.7 Middle East and Africa CMO of Sterile Injectable Drugs Market Forecast by Route of Administration
15.8 Middle East and Africa CMO of Sterile Injectable Drugs Market Forecast by Service
15.9 GCC CMO of Sterile Injectable Drugs Market Forecast, 2021-2031
15.9.1 GCC CMO of Sterile Injectables Market Outlook
15.9.2 GCC CMO of Sterile Injectables Market Revenue, 2021-2031
15.9.3 COVID-19 Impact Recovery Scenarios (V, U, W, L): GCC CMO of Sterile Injectable Drugs Market Forecast, 2021-2031
15.10 South Africa CMO of Sterile Injectable Drugs Market Forecast, 2021-2031
15.10.1 South Africa CMO of Sterile Injectables Market Outlook
15.10.2 South Africa CMO of Sterile Injectables Market Revenue, 2021-2031
15.10.3 COVID-19 Impact Recovery Scenarios (V, U, W, L): South Africa CMO of Sterile Injectable Drugs Market Forecast, 2021-2031
15.11 Rest of Middle East and Africa CMO of Sterile Injectable Drugs Market Forecast, 2021-2031
15.11.1 Rest of MEA CMO of Sterile Injectables Market Outlook
15.11.2 Rest of MEA CMO of Sterile Injectables Market Revenue, 2021-2031
15.11.3 COVID-19 Impact Recovery Scenarios (V, U, W, L): Rest of Middle East and Africa CMO of Sterile Injectable Drugs Market Forecast, 2021-2031
16 Company Profiles
16.1 Aenova Group
16.1.1 Company Snapshot
16.1.2 Company Overview
16.1.3 Product Benchmarking
16.1.4 Recent Developments
16.2 Almac Group
16.2.1 Company Snapshot
16.2.2 Company Overview
16.2.3 Product Benchmarking
16.2.4 Recent Developments
16.3 Baxter Biopharma Solutions
16.3.1 Company Snapshot
16.3.2 Company Overview
16.3.3 Financial Analysis
16.3.4 Product Benchmarking
16.3.5 Recent Developments
16.4 Boehringer Ingelheim
16.4.1 Company Snapshot
16.4.2 Company Overview
16.4.3 Financial Analysis
16.4.4 Product Benchmarking
16.5 Catalent, Inc.
16.5.1 Company Snapshot
16.5.2 Company Overview
16.5.3 Financial Analysis
16.5.4 Product Benchmarking
16.5.5 Recent Developments
16.6 CordenPharma
16.6.1 Company Snapshot
16.6.2 Company Overview
16.6.3 Product Benchmarking
16.6.4 Recent Developments
16.7 Evonik Industries AG
16.7.1 Company Snapshot
16.7.2 Company Overview
16.7.3 Financial Analysis
16.7.4 Product Benchmarking
16.8 Famar Health Care Services
16.8.1 Company Snapshot
16.8.2 Company Overview
16.8.3 Product Benchmarking
16.9 Fresenius Kabi Ag
16.9.1 Company Snapshot
16.9.2 Company Overview
16.9.3 Financial Analysis
16.9.4 Product Benchmarking
16.10 Grifols SA
16.10.1 Company Snapshot
16.10.2 Company Overview
16.10.3 Financial Analysis
16.10.4 Product Benchmarking
16.10.5 Recent Developments
16.11 Hikma Pharmaceuticals PLC
16.11.1 Company Snapshot
16.11.2 Company Overview
16.11.3 Financial Analysis
16.11.4 Product Benchmarking
16.11.5 Recent Developments
16.12 Jubilant Pharmova Limited
16.12.1 Company Snapshot
16.12.2 Company Overview
16.12.3 Financial Analysis
16.12.4 Product Benchmarking
16.13 Lonza
16.13.1 Company Snapshot
16.13.2 Company Overview
16.13.3 Financial Analysis
16.13.4 Product Benchmarking
16.13.5 Recent Developments
16.14 Patheon, Inc. (Thermo Fischer)
16.14.1 Company Snapshot
16.14.2 Company Overview
16.14.3 Financial Analysis
16.14.4 Product Benchmarking
16.15 Pfizer CentreOne
16.15.1 Company Snapshot
16.15.2 Company Overview
16.15.3 Financial Analysis
16.15.4 Product Benchmarking
16.16 Recipharm AB
16.16.1 Company Snapshot
16.16.2 Company Overview
16.16.3 Product Benchmarking
16.16.4 Recent Developments
16.17 Siegfried Holding AG
16.17.1 Company Snapshot
16.17.2 Company Overview
16.17.3 Financial Analysis
16.17.4 Product Benchmarking
17 Conclusion and Recommendations
17.1 Concluding Remarks
17.2 Recommendations
List of Tables
Table 1 Global CMO of Sterile Injectable Drugs Market Snapshot, 2021 & 2031 (US$ million, CAGR %)
Table 2 Global CMO of Sterile Injectables Market Forecast by Molecule Type, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 3 Global CMO of Sterile Injectables Market Forecast for Small Molecule Segment, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 4 Global CMO of Sterile Injectables Market Forecast for Small Molecule Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 5 Global CMO of Sterile Injectables Market Forecast for Small Molecule Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 6 Global CMO of Sterile Injectables Market Forecast for Small Molecule Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 7 Global CMO of Sterile Injectables Market Forecast for Small Molecule Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 8 Global CMO of Sterile Injectables Market Forecast for Large Molecule Segment, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 9 Global CMO of Sterile Injectables Market Forecast for Large Molecule Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 10 Global CMO of Sterile Injectables Market Forecast for Large Molecule Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 11 Global CMO of Sterile Injectables Market Forecast for Large Molecule Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 12 Global CMO of Sterile Injectables Market Forecast for Large Molecule Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 13 Global CMO of Sterile Injectables Market Forecast by Type, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 14 Global CMO of Sterile Injectables Market Forecast for Monoclonal Antibodies (mAbs) Segment, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 15 Global CMO of Sterile Injectables Market Forecast for Monoclonal Antibodies (mAbs) Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 16 Global CMO of Sterile Injectables Market Forecast for Monoclonal Antibodies (mAbs) Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 17 Global CMO of Sterile Injectables Market Forecast for Monoclonal Antibodies (mAbs) Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 18 Global CMO of Sterile Injectables Market Forecast for Monoclonal Antibodies (mAbs) Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 19 Global CMO of Sterile Injectables Market Forecast for Cytokines Segment, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 20 Global CMO of Sterile Injectables Market Forecast for Cytokines Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 21 Global CMO of Sterile Injectables Market Forecast for Cytokines Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 22 Global CMO of Sterile Injectables Market Forecast for Cytokines Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 23 Global CMO of Sterile Injectables Market Forecast for Cytokines Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 24 Global CMO of Sterile Injectables Market Forecast for Insulin Segment, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 25 Global CMO of Sterile Injectables Market Forecast for Insulin Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 26 Global CMO of Sterile Injectables Market Forecast for Insulin Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 27 Global CMO of Sterile Injectables Market Forecast for Insulin Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 28 Global CMO of Sterile Injectables Market Forecast for Insulin Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 29 Global CMO of Sterile Injectables Market Forecast for Peptide Hormones Segment, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 30 Global CMO of Sterile Injectables Market Forecast for Peptide Hormones Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 31 Global CMO of Sterile Injectables Market Forecast for Peptide Hormones Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 32 Global CMO of Sterile Injectables Market Forecast for Peptide Hormones Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 33 Global CMO of Sterile Injectables Market Forecast for Peptide Hormones Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 34 Global CMO of Sterile Injectables Market Forecast for Vaccines Segment, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 35 Global CMO of Sterile Injectables Market Forecast for Vaccines Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 36 Global CMO of Sterile Injectables Market Forecast for Vaccines Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 37 Global CMO of Sterile Injectables Market Forecast for Vaccines Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 38 Global CMO of Sterile Injectables Market Forecast for Vaccines Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 39 Global CMO of Sterile Injectables Market Forecast for Immunoglobulins Segment, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 40 Global CMO of Sterile Injectables Market Forecast for Immunoglobulins Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 41 Global CMO of Sterile Injectables Market Forecast for Immunoglobulins Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 42 Global CMO of Sterile Injectables Market Forecast for Immunoglobulins Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 43 Global CMO of Sterile Injectables Market Forecast for Immunoglobulins Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 44 Global CMO of Sterile Injectables Market Forecast for Blood Factors Segment, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 45 Global CMO of Sterile Injectables Market Forecast for Blood Factors Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 46 Global CMO of Sterile Injectables Market Forecast for Blood Factors Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 47 Global CMO of Sterile Injectables Market Forecast for Blood Factors Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 48 Global CMO of Sterile Injectables Market Forecast for Blood Factors Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 49 Global CMO of Sterile Injectables Market Forecast for Peptide Antibiotics Segment, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 50 Global CMO of Sterile Injectables Market Forecast for Peptide Antibiotics Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 51 Global CMO of Sterile Injectables Market Forecast for Peptide Antibiotics Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 52 Global CMO of Sterile Injectables Market Forecast for Peptide Antibiotics Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 53 Global CMO of Sterile Injectables Market Forecast for Peptide Antibiotics Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 54 Global CMO of Sterile Injectables Market Forecast for Others Segment, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 55 Global CMO of Sterile Injectables Market Forecast for Others Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 56 Global CMO of Sterile Injectables Market Forecast for Others Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 57 Global CMO of Sterile Injectables Market Forecast for Others Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 58 Global CMO of Sterile Injectables Market Forecast for Others Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 59 Global CMO of Sterile Injectables Market Forecast by Application, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 60 Global CMO of Sterile Injectables Market Forecast for Cancer Segment, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 61 Global CMO of Sterile Injectables Market Forecast for Cancer Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 62 Global CMO of Sterile Injectables Market Forecast for Cancer Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 63 Global CMO of Sterile Injectables Market Forecast for Cancer Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 64 Global CMO of Sterile Injectables Market Forecast for Cancer Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 65 Global CMO of Sterile Injectables Market Forecast for Diabetes Segment, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 66 Global CMO of Sterile Injectables Market Forecast for Diabetes Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 67 Global CMO of Sterile Injectables Market Forecast for Diabetes Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 68 Global CMO of Sterile Injectables Market Forecast for Diabetes Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 69 Global CMO of Sterile Injectables Market Forecast for Diabetes Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 70 Global CMO of Sterile Injectables Market Forecast for Cardiovascular Diseases Segment, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 71 Global CMO of Sterile Injectables Market Forecast for Cardiovascular Diseases Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 72 Global CMO of Sterile Injectables Market Forecast for Cardiovascular Diseases Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 73 Global CMO of Sterile Injectables Market Forecast for Cardiovascular Diseases Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 74 Global CMO of Sterile Injectables Market Forecast for Cardiovascular Diseases Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 75 Global CMO of Sterile Injectables Market Forecast for CNS Segment, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 76 Global CMO of Sterile Injectables Market Forecast for CNS Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 77 Global CMO of Sterile Injectables Market Forecast for CNS Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 78 Global CMO of Sterile Injectables Market Forecast for CNS Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 79 Global CMO of Sterile Injectables Market Forecast for CNS Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 80 Global CMO of Sterile Injectables Market Forecast for Infectious Segment, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 81 Global CMO of Sterile Injectables Market Forecast for Infectious Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 82 Global CMO of Sterile Injectables Market Forecast for Infectious Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 83 Global CMO of Sterile Injectables Market Forecast for Infectious Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 84 Global CMO of Sterile Injectables Market Forecast for Infectious Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 85 Global CMO of Sterile Injectables Market Forecast for Others Segment, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 86 Global CMO of Sterile Injectables Market Forecast for Others Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 87 Global CMO of Sterile Injectables Market Forecast for Others Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 88 Global CMO of Sterile Injectables Market Forecast for Others Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 89 Global CMO of Sterile Injectables Market Forecast for Others Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 90 Global CMO of Sterile Injectables Market Forecast by Container Type, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 91 Global CMO of Sterile Injectables Market Forecast for Bottles Segment, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 92 Global CMO of Sterile Injectables Market Forecast for Bottles Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 93 Global CMO of Sterile Injectables Market Forecast for Bottles Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 94 Global CMO of Sterile Injectables Market Forecast for
